Tuesday, July 16th, 2019

First Human Being Has Their DNA Manipulated To Make White Blood Cells 20 Years Younger

Published on April 29, 2016 by   ·   No Comments

DNA

CollectiveEvolution

Elizabeth Parris, the CEO of Bioviva USA Inc, has become the very first human being to successfully, from a biological standpoint, reverse the  age of her white blood cells, thanks to her own company’s experimental therapies. Bioviva utilizes intramural and extramural peer-reviewed research to create therapies for age-related diseases (Parkinson’s, Alzheimer’s, cancer, heart-disease), and now, they have reversed 20 years of ‘telomere shortening’ in a human for the first time.

Telomeres are short segments of DNA that cap the ends of every chromosome and act as a protective feature against wear and tear, which occurs naturally as the human body ages. As we age, these telomeres become shorter and shorter as our cells continue to divide more and more. Eventually they become too short to protect the chromosome, which is what causes our cells to malfunction and age related diseases to start setting in.

In September of last year, the 44 year old volunteered to partake in two of her own company’s experimental gene therapies; one intended to battle stem cell depletion, which happens when we age and leads to various age related diseases, and the other intended to protect against loss of muscle mass with age.

In Parrish’s case, specialized clinical testing in Houston, Texas, revealed that her telomeres were short for her age, which left her vulnerable to age-related diseases earlier on in life.

This type of gene therapy has been tested before, but prior to Parrish, it had only been used to lengthen the telomeres of cultured cells and mice; it has never before been tried on a human patient. The successful trial in mice was conducted by Maria Blasco and her team at the Spanish National Cancer Research Centre (CNIO) in Madrid, who reported the telomerase gene result in 2012.

Blasco told The Scientist in an email, “We demonstrated that AAV9-Tert gene therapy was sufficient to delay age-related pathologies and extend both median and maximum longevity in mice. Many pathologies were delayed, including cancer.” (source)

After the gene therapy was completed on Parrish, the company’s website revealed the astonishing results of the experiment:

Share the Truth:
  • Digg
  • Facebook
  • Twitter
  • Google Bookmarks
  • Global Grind
  • MySpace
  • Ping.fm
  • Tumblr
  • email

Readers Comments (0)




Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.

Daily News and Blogs

Listen to the TIS Network on blogtalkradio.com

Check Out Pop Culture Podcasts at Blog Talk Radio with TIS Network on BlogTalkRadio

Like us on Facebook

Advertise Here

Advertise Here